RecruitingNCT04510129

A Multicenter Cancer Biospecimen Collection Study

Predicting Immunotherapy Efficacy from Analysis of Pre-treatment Tumor Biopsies

Sponsor

Cofactor Genomics, Inc.

Enrollment

1,650 participants

Start Date

Feb 5, 2020

Study Type

OBSERVATIONAL

Conditions

Cancer of Head and Neck Lung Cancer, Nonsmall Cell

Summary

This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pre-treatment tumor biopsy or who have had a recent pre-treatment tumor biopsy. These specimens and clinical data may be used in subsequent studies for the development and validation of a diagnostic test.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects blood, tumor tissue, and other biological samples from people with certain cancers to help researchers discover new biomarkers — biological signals that may help identify who will respond best to future treatments. **You may be eligible if...** - You are 18 or older - You have one of the following cancers: head and neck squamous cell carcinoma, non-small cell lung cancer, small cell lung cancer, bladder/urothelial cancer, gastric or gastroesophageal junction cancer, cervical cancer, esophageal squamous cell cancer, or another qualifying cancer type - You are willing to provide blood and tissue samples **You may NOT be eligible if...** - You do not have one of the specified cancer types - You are unable to provide informed consent - You are not well enough to participate safely Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.